News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,500 Results
Type
Article (14103)
Company Profile (282)
Press Release (250115)
Section
Business (79452)
Career Advice (152)
Deals (13219)
Drug Delivery (35)
Drug Development (50408)
Employer Resources (31)
FDA (5704)
Job Trends (5136)
News (144305)
Policy (10030)
Tag
Academia (905)
Alliances (21604)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5707)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4573)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40568)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1151)
Diabetes (106)
Diagnostics (1278)
Earnings (29209)
Events (47654)
Executive appointments (353)
FDA (6211)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1073)
Healthcare (6569)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7247)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2576)
Medtech (2577)
Mergers & acquisitions (6206)
Metabolic disorders (316)
Neuroscience (1108)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1340)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25352)
Phase I (14314)
Phase II (18873)
Phase III (11932)
Pipeline (504)
Postmarket research (852)
Preclinical (5996)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1414)
Regulatory (8444)
Research institute (932)
Series A (82)
Southern California (1188)
Startups (1968)
United States (10533)
Vaccines (189)
Weight loss (96)
Date
Today (8)
Last 7 days (339)
Last 30 days (1515)
Last 365 days (20407)
2025 (2645)
2024 (20557)
2023 (22421)
2022 (26831)
2021 (27809)
2020 (23358)
2019 (16225)
2018 (11738)
2017 (13745)
2016 (11841)
2015 (14350)
2014 (10392)
2013 (7485)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17095)
Australia (2893)
California (3048)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36781)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1340)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1188)
Texas (337)
Washington State (291)
264,500 Results for "tenaya therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Tenaya Stock Crashes as Cardio Gene Therapy Delivers Underwhelming Early-Stage Data
Tenaya’s share slump following the TN-201 data drop could be due to its “significantly lower” level of RNA expression in the Phase Ib/II trial than in preclinical models, according to William Blair analysts.
December 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones
January 14, 2025
·
10 min read
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
Business
Tenaya Therapeutics Announces Research Leadership Updates
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced changes to its Research leadership team, including new appointments to the company’s Scientific Advisory Board (SAB).
June 27, 2024
·
5 min read
Business
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Tenaya Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 14, 2024
·
10 min read
Biotech Bay
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the TD Cowen Genetic Medicines & RNA Summit on Friday, June 21, 2024, at 11:20 am ET.
June 18, 2024
·
1 min read
Press Releases
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 19, 2024
·
1 min read
Press Releases
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 7, 2024
·
9 min read
Press Releases
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
September 3, 2024
·
1 min read
Deals
Tenaya Therapeutics Announces Pricing of Underwritten Offering
Tenaya Therapeutics, Inc. today announced the pricing of its underwritten offering of 8,888,890 shares of its common stock at an offering price of $4.50 per share.
February 8, 2024
·
4 min read
1 of 26,450
Next
